Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.
about
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceRegulation of EPCs: The Gateway to Blood Vessel FormationIntroduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicineMRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat gliomaCharacterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in GlioblastomaSuccessful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expressionTracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging.Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous SystemThe cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord bloodUmbilical cord blood: current status & promise for the future.Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesisCell therapy of peripheral arterial disease: from experimental findings to clinical trials.Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice.20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.CD34+ VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells.The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus.Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.Cord blood endothelial progenitor cells as therapeutic and imaging probes.Preparation of chitosan films using different neutralizing solutions to improve endothelial cell compatibility.Cellularity and structure of fresh human coronary thrombectomy specimens; presence of cells with markers of progenitor cellsIntravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings.Generation of osteogenic construct using periosteal-derived osteoblasts and polydioxanone/pluronic F127 scaffold with periosteal-derived CD146 positive endothelial-like cells.Angiogenic potential of endothelial progenitor cells and embryonic stem cells.Biofunctionalized quantum dots for live monitoring of stem cells: applications in regenerative medicine.Protective effects of HGF gene-expressing human mesenchymal stem cells in acetaminophen-treated hepatocytes.Circulating endothelial progenitors in vascular repair.
P2860
Q21131825-940BD0BD-03B9-4FC4-B792-A062136A42C0Q21284530-50096B6A-1F59-45FB-97C9-62A8476C5AE0Q27027618-4B8EA529-52AE-4CBE-AC44-6682C29378EFQ27302331-6988AF50-F917-4910-8DEE-F6331BBBB336Q27315171-DD206789-37D5-4008-87F0-BB96CC6D2191Q33868524-46B7982A-93B2-4EC8-BE0D-EA93EB33DC07Q33999277-5EB86257-4EF5-4FE6-A142-AE98B6C5E16AQ34502807-B2AD265E-A47F-4825-8F80-C7DC96467735Q34975310-7540E2F5-5F40-40CD-B575-0F7C14632AAFQ35122891-411A6002-8D81-4A09-A7C4-F6DF0B2FBDBCQ35351684-CD2FBA3E-2971-4243-8911-1D157E5C663BQ36861476-F981CB93-60D2-4732-B7FB-90B9A97A433DQ37338896-3FFA2386-7C83-4161-A7A8-959FEDBFAF83Q37458674-1DA30D21-A92F-4884-BAAC-1D71434C4483Q37589340-77F93A25-88B8-451F-BC60-3755E11ADE52Q37603893-3F3860B2-9E17-4120-AF18-6D04F7780C34Q37638906-B0EBD96F-DAF5-4BB1-924B-DAB178B460C4Q37931911-643885C8-FE30-4303-9766-309981E25061Q37993772-A4C5EF66-ADE7-42A0-8CD5-B5346F9F8DF8Q38066215-DCD7CF64-C950-49C7-B6E3-9549ECB12A3FQ39449934-7503F556-6CB4-4196-BD90-6365CFC3F1A6Q39529000-44982893-FE8A-41CD-842B-0AC68576880FQ41874996-C33DB5A6-2706-4F60-9FEE-C77F05DF4E73Q42512412-20415F77-80F4-462E-A9D9-F829B4712B66Q42747347-35503233-0599-49C9-A4FA-81A719135A13Q49168851-DA46B44F-8A2A-4AC4-8E39-96AC9EE1C1F7Q51645631-6193B1F1-A88C-4F51-AC62-B59C46A4444FQ52884407-1AF5C71B-E8C4-485B-8EFC-FB62892AB30D
P2860
Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human cord blood-derived AC133 ...... long term in vitro expansion.
@ast
Human cord blood-derived AC133 ...... long term in vitro expansion.
@en
Human cord blood-derived AC133 ...... long term in vitro expansion.
@nl
type
label
Human cord blood-derived AC133 ...... long term in vitro expansion.
@ast
Human cord blood-derived AC133 ...... long term in vitro expansion.
@en
Human cord blood-derived AC133 ...... long term in vitro expansion.
@nl
prefLabel
Human cord blood-derived AC133 ...... long term in vitro expansion.
@ast
Human cord blood-derived AC133 ...... long term in vitro expansion.
@en
Human cord blood-derived AC133 ...... long term in vitro expansion.
@nl
P2093
P2860
P1433
P1476
Human cord blood-derived AC133 ...... long term in vitro expansion.
@en
P2093
A S M Iskander
Alfonso G Scicli
Ali S Arbab
Austin M Guo
Branislava Janic
Nadimpalli Ravi S Varma
P2860
P356
10.1371/JOURNAL.PONE.0009173
P407
P577
2010-02-11T00:00:00Z